Show simple item record

FieldValueLanguage
dc.contributor.authorHueneburg, Thomas
dc.date.accessioned2024-06-19T05:06:32Z
dc.date.available2024-06-19T05:06:32Z
dc.date.issued2024en_AU
dc.identifier.urihttps://hdl.handle.net/2123/32674
dc.description.abstractIn Australia, oncology patients receive up to 60% of platelet transfusions. Interactions between platelets and cancer cells in oncology patients are well documented, notably, crosstalk between the C-type like lectin receptor on platelets and podoplanin (PDPN) on malignant cells. Described here is the first in-vitro investigation of crosstalk between stored apheresis platelets and cancer cells. Platelets were stored for 7 days at 20-24°C with constant agitation. During storage, samples were taken and interactions with HepG2, H226 and A549 cells were examined. The potential of malignant cells to induce platelet aggregation was measured using light transmission aggregometry with 1.25 mM CaCl2 (n=5), and platelet phenotypes were determined using flow cytometry (n=3), as was titration of an antibody to block PDPN (n=5). Blocking the interaction between platelets and malignant cells was examined using LTA (n=3). A 24-well plate assay was developed to investigate the interactions between platelets and malignant cells (n=3) using 1.25 mM CaCl2 and 2.5 mM GPRP. Changes within groups were analysed by one-way ANOVA, and two-way ANOVA; p<0.05 was significant. HepG2, H226 and A549 cells induced platelet aggregation, which was reduced when platelets were stored for longer. Blocking PDPN with an anti-PDPN antibody did not prevent cancer cell induced aggregation, suggesting multiple pathways may mediate platelet aggregation. The interactions of platelets with malignant cells in a 24-well plate led to a reduction in platelet receptors and increased platelet activation with release of CD62P and externalisation of phosphatidylserine. TGF-ß release was highest following the incubation of platelets with A549 cells with GPRP and CaCl2. In conclusion, the incubation of platelets with cells derived from solid tumour induced platelet activation and aggregation, leading to a marked reduction of platelet glycoproteins. These alterations were more marked during early platelet storage.en_AU
dc.language.isoenen_AU
dc.subjectcanceren_AU
dc.subjectmalignanciesen_AU
dc.subjectplateletsen_AU
dc.subjecttransfusionen_AU
dc.subjectstorageen_AU
dc.subjectcrosstalken_AU
dc.titleCROSSTALK BETWEEN PLATELETS AND CANCER CELLS: Do cancer cells interact with transfused platelets?en_AU
dc.typeThesis
dc.type.thesisDoctor of Philosophyen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Northern Clinical Schoolen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorWARD, CHRISTOPHER
usyd.include.pubNoen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.